DNA cytosine methylation profile in various cancer-related genes is altered in cultured rat hepatocyte cell lines as compared with primary hepatocytes

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1241-1248

  Asada, Kiyoshi ^a,c   Asada, Rumiko ^c   Yoshiji, Hitoshi ^a   Fukui, Hiroshi ^a   Floyd, Robert A ^c   Kotake, Yashige ^b,c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Clone 9 and CWSV 1; Dlc 1; DNA cytosine methylation; Hepatocyte; Hic 1; p16; Rassf1A; Socs 1; Timp 1; Timp 2; Timp 3

Indexed keywords

CYTOSINE; RNA; SULFITE;

ANIMAL; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CPG ISLAND; CULTURE TECHNIQUE; DNA METHYLATION; GENETICS; LIVER CELL; METABOLISM; NEOPLASM; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GENE;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CPG ISLANDS; CYTOSINE; DNA METHYLATION; GENES, NEOPLASM; HEPATOCYTES; NEOPLASMS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SULFITES;

EID: 33745008864     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1241     Document Type: Article

References (55)

1. Briand P and Lykkesfeldt AE: An in vitro model of human breast carcinogenesis: epigenetic aspects. Breast Cancer Res Treat 65: 179-187, 2001. (Pubitemid 32193622)
2. Katdare M, Osborne MP and Telang NT: Novel cell culture models for prevention of human breast cancer (Review). Int J Oncol 22: 509-515, 2003.
3. Schrump DS and Nguyen DM: Targeting the epigenome for the treatment and prevention of lung cancer. Semin Oncol 32: 488-502, 2005. (Pubitemid 41396426)
4. Marian B: In vitro models for the identification and characterization of tumor-promoting and protective factors for colon carcinogenesis. Food Chem Toxicol 40: 1099-1104, 2002.
5. Stampfer MR and Yaswen P: Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett 194: 199-208, 2003. (Pubitemid 36577331)
6. Lambert JD, Hong J, Yang GY, Liao J and Yang CS: Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am J Clin Nutr 81: 284S-291S, 2005.
7. Tannapfel A, Busse C, Weinans L, et al: INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 20: 7104-7109, 2001. (Pubitemid 33052203)
8. Ito T, Nishida N, Fukuda Y, Nishimura T, Komeda T and Nakao K: Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas. J Gastroenterol 39: 355-361, 2004. (Pubitemid 38678784)
9. Locker J, Hutt S and Lombardi B: Alpha-fetoprotein gene methylation and hepatocarcinogenesis in rats fed a choline-devoid diet. Carcinogenesis 8: 241-246, 1987.
10. Lopatina NG, Vanyushin BF, Cronin GM and Poirier LA: Elevated expression and altered pattern of activity of DNA methyltransferase in liver tumors of rats fed methyl-deficient diets. Carcinogenesis 19: 1777-1781, 1998. (Pubitemid 28474641)
11. Motiwala T, Ghoshal K, Das A, et al: Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas. Oncogene 22: 6319-6331, 2003. (Pubitemid 37281680)
12. INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Lett 187: 69-75, 2002.
13. Steinmetz KL, Pogribny IP, James SJ and Pitot HC: Hypomethylation of the rat glutathione S-transferase pi (GSTP) promoter region isolated from methyl-deficient livers and GSTP-positive liver neoplasms. Carcinogenesis 19: 1487-1494, 1998. (Pubitemid 28409849)
14. Tsujiuchi T, Tsutsumi M, Sasaki Y, Takahama M and Konishi Y: Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline-deficient L-amino acid-defined diet in rats. Jpn J Cancer Res 90: 909-913, 1999. (Pubitemid 29500427)
15. Zapisek WF, Cronin GM, Lyn-Cook BD and Poirier LA: The onset of oncogene hypomethylation in the livers of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 13: 1869-1872, 1992.
16. Kempe KC, Isom HC and Greene FE: Responsiveness of an SV40-immortalized hepatocyte cell line to growth hormone. Biochem Pharmacol 49: 1091-1098, 1995.
17. Zeisel SH, Albright CD, Shin OH, Mar MH, Salganik RI and da Costa KA: Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis 18: 731-738, 1997. (Pubitemid 28132460)
18. Starr R, Willson TA, Viney EM, et al: A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921, 1997. (Pubitemid 27289594)
19. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP: Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319, 2000. (Pubitemid 30437320)
20. Wales MM, Biel MA, el Deiry W, et al: p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1: 570-577, 1995.
21. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS and Popescu NC: Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58: 2196-2199, 1998. (Pubitemid 28232908)
22. Fassina G, Ferrari N, Brigati C, Benelli R, Santi L, Noonan DM and Albini A: Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis 18: 111-120, 2000. (Pubitemid 32165244)
23. Asada K, Miyamoto K, Fukutomi T, et al: Reduced expression of GNA11 and silencing of MCT1 in human breast cancers. Oncology 64: 380-388, 2003. (Pubitemid 36682952)
24. Swafford DS, Middleton SK, Palmisano WA, et al: Frequent aberrant methylation of p16INK4a in primary rat lung tumors. Mol Cell Biol 17: 1366-1374, 1997. (Pubitemid 27097365)
25. Phillips PA, McCarroll JA, Park S, et al: Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut 52: 275-282, 2003. (Pubitemid 36115072)
26. Yu J, Ni M, Xu J, et al: Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2: 29, 2002.
27. Yang B, Guo M, Herman JG and Clark DP: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163: 1101-1107, 2003. (Pubitemid 37040145)
28. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ and Kang GH: Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am J Pathol 163: 1371-1378, 2003. (Pubitemid 37175085)
29. Gibbs RA, Weinstock GM, Metzker ML, et al: Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428: 493-521, 2004.
30. Ushijima T, Watanabe N, Shimizu K, Miyamoto K, Sugimura T and Kaneda A: Decreased fidelity in replicating CpG methylation patterns in cancer cells. Cancer Res 65: 11-17, 2005. (Pubitemid 40070790)
31. Jin M, Piao Z, Kim NG, et al: p16 is a major inactivation target in hepatocellular carcinoma. Cancer 89: 60-68, 2000. (Pubitemid 30451274)
32. INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res 58: 3508-3512, 1998.
33. Antequera F, Boyes J and Bird A: High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-514, 1990.
34. Foster SA, Wong DJ, Barrett MT and Galloway DA: Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 18: 1793-1801, 1998. (Pubitemid 28152628)
35. Jones PA, Wolkowicz MJ, Rideout WM III, Gonzales FA, Marziasz CM, Coetzee GA and Tapscott SJ: De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-6121, 1990.
36. Endo TA, Masuhara M, Yokouchi M, et al: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921-924, 1997. (Pubitemid 27289595)
37. Naka T, Narazaki M, Hirata M, et al: Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924-929, 1997. (Pubitemid 27289596)
38. Yoshikawa H, Matsubara K, Qian GS, et al: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28: 29-35, 2001. (Pubitemid 32405812)
39. Melzner I and Moller P: Silencing of the SOCS-1 gene by CpG methylation? Blood 102: 1554-1555, 2003. (Pubitemid 36988075)
40. Zhong S, Yeo W, Tang MW, Wong N, Lai PB and Johnson PJ: Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res 9: 3376-3382, 2003. (Pubitemid 37086674)
41. Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H and Hirohashi S: DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology 29: 703-709, 1999. (Pubitemid 29109583)
42. Chen W, Cooper TK, Zahnow CA, et al: Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6: 387-398, 2004. (Pubitemid 39361439)
43. Greene J, Wang M, Liu YE, Raymond LA, Rosen C and Shi YE: Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375-30380, 1996. (Pubitemid 26404039)
44. Hammani K, Blakis A, Morsette D, Bowcock AM, Schmutte C, Henriet P and DeClerck YA: Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J Biol Chem 271: 25498-25505, 1996. (Pubitemid 26337925)
45. Cameron EE, Bachman KE, Myohanen S, Herman JG and Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107, 1999. (Pubitemid 29036293)
46. Esteller M, Corn PG, Baylin SB and Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001. (Pubitemid 32695003)
47. Matsumoto E, Nakatsukasa H, Nouso K, et al: Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma. Liver Int 24: 379-383, 2004. (Pubitemid 39162078)
48. Yamamoto H, Itoh F, Adachi Y, et al: Messenger RNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human hepatocellular carcinoma. Jpn J Clin Oncol 29: 58-62, 1999.
49. Nakatsukasa H, Ashida K, Higashi T, et al: Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Hepatology 24: 82-88, 1996. (Pubitemid 26249417)
50. Yamauchi K, Ogata Y, Nagase H and Shirouzu K: Inhibition of liver metastasis from orthotopically implanted colon cancer in nude mice by transfection of the TIMP-1 gene into KM12SM cells. Surg Today 31: 791-798, 2001. (Pubitemid 32955324)
51. Anderson CL and Brown CJ: Variability of X chromosome inactivation: effect on levels of TIMP1 RNA and role of DNA methylation. Hum Genet 110: 271-278, 2002. (Pubitemid 36067448)
52. Yuan BZ, Durkin ME and Popescu NC: Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers. Cancer Genet Cytogenet 140: 113-117, 2003. (Pubitemid 36349010)
53. Zhou X, Thorgeirsson SS and Popescu NC: Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23: 1308-1313, 2004. (Pubitemid 38297186)
54. Weinstein IB, Orenstein JM, Gebert R, Kaighn ME and Stadler UC: Growth and structural properties of epithelial cell cultures established from normal rat liver and chemically induced hepatomas. Cancer Res 35: 253-263, 1975.
55. Reuber MD: A transplantable bile-secreting hepatocellular carcinoma in the rat. J Natl Cancer Inst 26: 891-899, 1961. Health